As of close of business last night, HashiCorp Inc’s stock clocked out at $23.43, down -4.56% from its previous closing price of $24.55. On the day, 1854514 shares were traded.
Ratios:
To gain a deeper understanding of HCP’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.38 and its Current Ratio is at 3.38. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
On March 12, 2024, Scotiabank Upgraded its rating to Sector Outperform which previously was Sector Perform but kept the price unchanged to $31.
Morgan Stanley Upgraded its Equal-Weight to Overweight on February 26, 2024, whereas the target price for the stock was revised from $23 to $30.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 10 ’24 when Holmes Marc sold 13,916 shares for $26.30 per share. The transaction valued at 366,031 led to the insider holds 0 shares of the business.
Dadgar Armon sold 35,904 shares of HCP for $922,392 on Apr 02 ’24. The CHIEF TECHNOLOGY OFFICER now owns 1,661,164 shares after completing the transaction at $25.69 per share. On Mar 22 ’24, another insider, Dadgar Armon, who serves as the CHIEF TECHNOLOGY OFFICER of the company, sold 35,904 shares for $27.09 each. As a result, the insider received 972,629 and left with 1,697,068 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 8.05 while its Price-to-Book (P/B) ratio in mrq is 3.85.
Stock Price History:
Over the past 52 weeks, HCP has reached a high of $36.39, while it has fallen to a 52-week low of $18.91.
Shares Statistics:
A total of 125.33M shares are outstanding, with a floating share count of 113.19M. Insiders hold about 43.51% of the company’s shares, while institutions hold 47.27% stake in the company.
Earnings Estimates
As of right now, Canadian Pacific Kansas City Li analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is $322.63, with high estimates of $41.63 and low estimates of $23.43.
Analysts are recommending an EPS of between $Energy and $Technology for the fiscal current year, implying an average EPS of $Healthcare.
